Scleroderma, Diffuse: all 534 studies
Page 6 of 6. Open to participants first (115), then studies with results posted, then the rest; newest registration first within each.
- Mycophenolate Mofetil in Systemic SclerosisCompletedNCT00433186Phase 1
- High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic SclerosisStatus unknownNCT00428883Phase 2/3
- Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic SclerosisTerminatedNCT00418132Phase 1
- A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), RituximabCompletedNCT00379431Phase 2
- Dose Response Study of a Topical Gel for the Treatment of Raynaud's PhenomenonCompletedNCT00378521Phase 2
- Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma PatientsCompletedNCT00377949
- Premature Coronary Atherosclerosis in SclerodermaCompletedNCT00372398
- Efficacy and Safety Study of GB-0998 for Treatment of Systemic SclerosisCompletedNCT00348296Phase 3
- Open-label Study With Bosentan in Interstitial Lung DiseaseCompletedNCT00319033Phase 2/3
- Effects of a Personalized Standardized Rehabilitation Program in Systemic SclerosisCompletedNCT00318188Not applicable
- Effect of Bosentan on Skin Fibrosis in Patients With Systemic SclerosisCompletedNCT00318175Phase 2
- Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic SclerosisTerminatedNCT00282425Phase 1
- Rapamycin vs Methotrexate in Diffuse SScCompletedNCT00241189Phase 1/2
- Treatment of Early Systemic Sclerosis by BosentanTerminatedNCT00226889Phase 1/2
- Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 ControlsCompletedNCT00213525
- Small Bowel Motor Impairment in Scleroderma: Results of a Prospective 5-year Manometric Follow-upCompletedNCT00213460
- Imiquimod in Children With Plaque MorpheaCompletedNCT00147771Phase 3
- Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal MatrixCompletedNCT00129428Phase 1/2
- Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With SclerodermaCompletedNCT00077584Phase 3
- Scleroderma RegistryCompletedNCT00074568
- Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With SclerodermaCompletedNCT00070590Phase 2/3
- Stem Cell Transplant to Treat Patients With Systemic SclerosisCompletedNCT00058578Phase 1
- Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic SclerosisCompletedNCT00043706Phase 1/2
- Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma PatientsTerminatedNCT00040651Phase 1
- Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye SyndromeCompletedNCT00025818Phase 3
- Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic SclerosisCompletedNCT00016458Phase 2
- Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune DisordersCompletedNCT00010335Phase 1
- Psychological Treatments for SclerodermaCompletedNCT00007267Phase 2
- Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients With Systemic SclerosisStatus unknownNCT00006393
- Oral Type I Collagen for Relieving SclerodermaCompletedNCT00005675Phase 2
- Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung DiseasesCompletedNCT00005317
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT00004786Phase 3
- Phase II Study of Recombinant Relaxin for Progressive Systemic SclerosisCompletedNCT00004380Phase 2
- Study of Silicone-Associated Connective Tissue DiseasesCompletedNCT00001330